Kappadione
Jump to navigation
Jump to search
Clinical data | |
---|---|
Routes of administration | Injection |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.558 |
Chemical and physical data | |
Formula | C11H8Na4O8P2 |
Molar mass | 422.084 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Kappadione is a vitamin K derivative used for the treatment of side effects of vitamin K antagonists such as warfarin, prophylaxis and treatment of vitamin K deficiency bleeding, and hypoprothrombinemia due to various causes.[1] It was manufactured by Eli Lilly and Company.[2] Chemically, it is menadiol sodium diphosphate. It was approved by the US Food and Drug Administration prior to 1982 and marketed by Lilly. It has since been discontinued and is not available in North America.[1]
References
- ^ a b DrugBank DB09332 . Accessed 21 April 2021.
- ^ "Kappadione overview, medicine.org". Archived from the original on 2016-03-03. Retrieved 2008-04-14.
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- Articles with changed ChemSpider identifier
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Articles without EBI source
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Drugs developed by Eli Lilly and Company
- Organophosphates
- Naphthol esters
- Organic sodium salts
- All stub articles
- Blood and blood forming organ drug stubs